CUSTOM II

Our CUSTOM II clinical trial was designed to evaluate the safety of in situ customization for long lesions and multiple lesions using the XTENT^® Custom NX^® 60 DES System. Enrollment of 100 patients was completed in October 2006 at 10 cardiology centers in Europe, with patient follow up at 30 days, six months and annually for 5 years.